More recently, miR-124-3p was reported to be downregulated in breast cancer cells, where it inhibited cell proliferation and metastasis by targeting N-acetylglucosaminyltransferase V (MGAT5), a tumorigenesis and metastasis-associated enzyme in breast cancer [61]. This evidence concerns the gene MGAT5 and breast cancer.